• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, August 23, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

UTSW study finds Hispanic people receive lower-quality thrombectomies than white people

Bioengineer by Bioengineer
November 16, 2021
in Biology
Reading Time: 2 mins read
0
faculty
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A study involving UT Southwestern neurology researchers found lower-quality outcomes for Hispanic ischemic stroke patients who receive endovascular thrombectomies than for comparable white and Black patients.

faculty

Credit: UT Southwestern Medical Center

A study involving UT Southwestern neurology researchers found lower-quality outcomes for Hispanic ischemic stroke patients who receive endovascular thrombectomies than for comparable white and Black patients.

Outcomes were similar between Black and white ischemic stroke patients who receive endovascular thrombectomies, the researchers determined. Ischemic strokes block or narrow an artery leading to the brain.

The findings, published in the Journal of Stroke and Cerebrovascular Diseases, add to the body of knowledge on improving stroke treatment in underserved groups. Previous studies have identified racial disparities in stroke treatments. This study involving more than 660 patients in the Houston area focused on thrombectomies, the surgical procedure to remove blood clots from arteries and veins.

Ischemic stroke is the fifth leading cause of death in the United States. Of all strokes 87% are ischemic. A 2017 study found that thrombectomy treatment within 24 hours after an acute stroke can result in a 73% lower risk of disability.

“This new study identifies populations that we should focus on in future research to gain a better understanding of the root causes of these disparities. With understanding, targeted interventions can be developed to improve access to the best outcomes for all stroke patients,” said the study’s lead author, Erica Jones, M.D., M.P.H., Assistant Professor of Neurology.

The American Heart Association and the American Stroke Association certified the UT Southwestern is an Advanced Comprehensive Stroke Center, which is part of the Peter O’Donnell Jr. Brain Institute. UT Southwestern has earned High Performing recognition for treatment of strokes from U.S. News & World Report, placing it among the best hospitals for stroke care in the U.S.

Dr. Jones is a member of the Stroke Editor Training Program as well as the American Academy of Neurology, the American Heart Association, and the Society of Vascular and Interventional Neurology.

Her study builds on research Dr. Jones published in 2020, which found that among stroke patients under age 50, there was a higher prevalence of modifiable risk factors among Black and Hispanic patients as well as a decreased likelihood to have good early functional outcomes after ischemic stroke. The modifiable risk factors included diabetes, hypertension, and heart failure.

The study was funded by a National Institutes of Health T32 training grant.

About UT Southwestern Medical Center

UT Southwestern, one of the nation’s premier academic medical centers, integrates pioneering biomedical research with exceptional clinical care and education. The institution’s faculty has received six Nobel Prizes, and includes 25 members of the National Academy of Sciences, 16 members of the National Academy of Medicine, and 14 Howard Hughes Medical Institute Investigators. The full-time faculty of more than 2,800 is responsible for groundbreaking medical advances and is committed to translating science-driven research quickly to new clinical treatments. UT Southwestern physicians provide care in about 80 specialties to more than 117,000 hospitalized patients, more than 360,000 emergency room cases, and oversee nearly 3 million outpatient visits a year.



Journal

Journal of Stroke and Cerebrovascular Diseases

Share12Tweet8Share2ShareShareShare2

Related Posts

Delayed antiviral response in alveolar type 2 cells heightens influenza susceptibility

Delayed antiviral response in alveolar type 2 cells heightens influenza susceptibility

August 22, 2026
Genetic evidence links sleep disruption to hemorrhoidal disease, revealing a hidden connection

Genetic evidence links sleep disruption to hemorrhoidal disease, revealing a hidden connection

August 22, 2026

LASIK Versus Contact Lenses for Correcting Myopia

August 22, 2026

New Advances in Minimally Invasive Laryngeal Surgery

August 22, 2026

POPULAR NEWS

  • Blocking glucosylceramide production kills cancer cells via lysosomal dysfunction, not ceramide buildup

    29 shares
    Share 12 Tweet 7
  • ZCCHC4 boosts replication-dependent histone mRNA translation by interacting with eIF3

    29 shares
    Share 12 Tweet 7
  • KAIST Surface Defects Boost Droplet Formation, Removal, and Heat Transfer by 5.5-Fold

    29 shares
    Share 12 Tweet 7
  • Dual-oxygen pancreatic cancer organoids mirror basal-classical diversity, spatial transcriptomics confirms

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Blocking glucosylceramide production kills cancer cells via lysosomal dysfunction, not ceramide buildup

ZCCHC4 boosts replication-dependent histone mRNA translation by interacting with eIF3

KAIST Surface Defects Boost Droplet Formation, Removal, and Heat Transfer by 5.5-Fold

Subscribe to Blog via Email

Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.